{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02172885",
      "OrgStudyIdInfo": {
        "OrgStudyId": "EudraCT Number:2012-002553-38"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "Health Department of Spain",
            "SecondaryIdType": "Other Grant/Funding Number",
            "SecondaryIdDomain": "EC10-219"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Hospital de Cruces",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
      "OfficialTitle": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
      "Acronym": "TERCELOI"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2019",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2018",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2018",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 12, 2014",
      "StudyFirstSubmitQCDate": "June 23, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 24, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "March 22, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 26, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Clara I. Rodríguez",
        "ResponsiblePartyInvestigatorTitle": "PI Stem Cell Laboratory",
        "ResponsiblePartyInvestigatorAffiliation": "Hospital de Cruces"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Hospital de Cruces",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Hospital Universitario Getafe",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Hospital Infantil Universitario Niño Jesús, Madrid, Spain",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to determine the safety and effectiveness of five infusions of characterized HLA-identical MSC in non immunosuppressed children with Osteogenesis Imperfecta (OI).",
      "DetailedDescription": "The principal aim of this trial is to assess the safety of non-mutated HLA-identical Mesenchymal stem cell (MSC) transplantation for OI pediatric patients irrespective of treatment with biphosphonates. Since MSC are inherently non-immunogenic and do not elicit proliferation of allogeneic lymphocytes (in co-culture experiments), a cell therapy based on HLA-identical or histocompatible (at least 5 shared out of 6 HLA antigens) allogenic MSC may be accomplished without subjecting the patients to immunosuppressor treatment. Adverse secondary effects due to immunosuppressor treatment will be avoided using this strategy thus patients may benefit from two cellular infusions. The patients will be followed for 2 years post their fifth and last MSC infusion."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteogenesis Imperfecta"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Mesenchymal stem cell based therapy",
          "cell infusion"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "2",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Five Mesenchymal Stem Cell infusions",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Mesenchymal Stem Cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Mesenchymal Stem Cells",
            "InterventionDescription": "Mesenchymal Stem Cell Infusions",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Mesenchymal stem cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Adverse Events as a Measure of Safety",
            "PrimaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "bone mineral density",
            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          },
          {
            "SecondaryOutcomeMeasure": "fracture rate",
            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          },
          {
            "SecondaryOutcomeMeasure": "growth velocity",
            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          },
          {
            "SecondaryOutcomeMeasure": "change from baseline in degree of functionality",
            "SecondaryOutcomeDescription": "9 question survey using a Bleck functional scale",
            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          },
          {
            "SecondaryOutcomeMeasure": "change from baseline in well-being",
            "SecondaryOutcomeDescription": "A 20 item questionnaire designed to evaluate the well-being will be used",
            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatient age: older than 6 months and younger than 12 years old.\nPatients with molecular confirmation of mutation in either COL1A1 or COL1A2 genes associated with OI (type III).\nPatients with HLA identical (that shared at least 5/6 antigens) siblings willing to donate bone marrow-MSCs.\nAll patients that fulfil the inclusion criteria regardless of whether or not they are undergoing biphosphonate treatment.\nPatients whose parents or the legal guardians are willing to sign the consent forms to participate in this clinical trial.\n\nExclusion Criteria:\n\nPatient age: older than 12 years old\nPatients lacking confirmation of mutation in either COL1A1 or COL1A2 genes associated with severe deforming OI (type III).\nOther pathological subtypes of OI.\nPatients lacking of HLA identical (that shared at least 5/6 antigens) siblings willing to donate bone marrow-MSCs.\nImmunodeficiencies and any other malignancies.\nParticipation in other clinical trial.\nAny medical or psychiatric condition that in the researcher´s opinion could affect the patient´s ability to complete the trial or hamper the participation in the trial.\nPatients whose parents or the legal guardians do not sign the consent forms",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "6 Months",
      "MaximumAge": "12 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Clara I. Rodríguez, Ph. D.",
            "OverallOfficialAffiliation": "BioCruces Health Research Institute/Cruces University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital Universitario Cruces",
            "LocationCity": "Barakaldo",
            "LocationState": "Bizkaia",
            "LocationZip": "48903",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital Universitario Getafe",
            "LocationCity": "Getafe",
            "LocationState": "Madrid",
            "LocationCountry": "Spain"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010013",
            "ConditionMeshTerm": "Osteogenesis Imperfecta"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010009",
            "ConditionAncestorTerm": "Osteochondrodysplasias"
          },
          {
            "ConditionAncestorId": "D000001848",
            "ConditionAncestorTerm": "Bone Diseases, Developmental"
          },
          {
            "ConditionAncestorId": "D000001847",
            "ConditionAncestorTerm": "Bone Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionAncestorId": "D000003095",
            "ConditionAncestorTerm": "Collagen Diseases"
          },
          {
            "ConditionAncestorId": "D000003240",
            "ConditionAncestorTerm": "Connective Tissue Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12088",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M12084",
            "ConditionBrowseLeafName": "Osteochondrodysplasias",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11195",
            "ConditionBrowseLeafName": "Mucopolysaccharidosis IV",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4278",
            "ConditionBrowseLeafName": "Bone Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4279",
            "ConditionBrowseLeafName": "Bone Diseases, Developmental",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5616",
            "ConditionBrowseLeafName": "Connective Tissue Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4306",
            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T3909",
            "ConditionBrowseLeafName": "Mucopolysaccharidosis Type IV",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}